Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors for Cultivated Seafood Production
Solaris Pharma's Generic Clobetasol Propionate Receives Approval in the U.S.
Solaris Pharma's Generic Clindamycin and Tretinoin Receives Approval in the U.S.
BRIDGEWATER, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris”) announced today that the U.S. Food and Drug Administration (FDA) has approved its abbreviated new drug application (ANDA) for a generic version of Metrogel-Vaginal® (metronidazole vaginal gel 0.75%) by Bausch Health. This product will be launched immediately.
Solaris Pharma’s Generics Metronidazole Receives Approvals In US